FDA 510(k), K231337, EndeavorRx
FDA 510(k), K231337, EndeavorRx
Device Name: EndeavorRx
Manufacturer: Bhupinder Singh
Device Classification Name: Digital Therapeutic Software For Attention Deficit Hyperactivity Disorder
Regulation Number: QFT
Classification Product Code: KXA
Date Received: 05/08/2023
Decision Date: 12/13/2023
Decision: Substantially Equivalent (SESE)
Regulation Medical Specialty: Neurology
Couldn't load pickup availability
PLEASE NOTE: Most 510(k)s obtained through FOIA are heavily redacted, often omitting sections related to testing, software, manufacturing, and other technical data. Please be sure to review the total pages, redacted pages, and content pages listed in the description to get a sense of how much of the document is redacted. As the FDA FOIA office explains: “We HEAVILY REDACT the majority of the following portions of 510(k) filings: testing data, technical data, lab reports, manufacturing information, vendor information, substantive discussions regarding deficiencies or additional information requests, internal FDA communications, software and risk analysis, specifications, SOPs, unpublished studies, draft manuals, etc.” If you’d like more details about a specific document before purchasing, please contact us at info@foiadocs.com.
View full details